ArticleJCI insight2022

BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasm.

Gerardo Lopez-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.